Literature DB >> 6177003

Genetic analysis of the role of cAMP in mediating effects of interferon.

J Schneck, B Rager-Zisman, O M Rosen, B R Bloom.   

Abstract

The effects of interferon (IFN) on Fc receptor-mediated phagocytosis, intracellular cAMP levels, antiviral activity, and growth inhibition were analyzed in a cloned macrophage-like cell line, J774.2, and variants derived from it. Purified IFN increased Fc receptor-mediated phagocytosis in J774.2 cells, and in cAMP-responsive nonphagocytic variants but was without effect in cAMP-unresponsive nonphagocytic variants, in adenylate cyclase-deficient variants, and in cAMP-dependent protein kinase-deficient variants. Under conditions in which IFN augmented phagocytosis, it increased intracellular levels of cAMP. Parental cells were highly sensitive to IFN-mediated growth inhibition. In contrast, cAMP-dependent protein kinase-deficient variants were only 1/100th as sensitive to growth inhibition by IFN. All cell lines tested, both responsive and unresponsive to cAMP, were equally protected by IFN against infection with vesicular stomatitis virus, demonstrating that the antiviral state was independent of cAMP. These results indicate that, in transformed macrophages, stimulation of phagocytosis and inhibition of growth by IFN are mediated through intracellular cAMP, whereas the antiviral state induced by IFN is independent of cAMP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177003      PMCID: PMC346084          DOI: 10.1073/pnas.79.6.1879

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Modulation of Fc-mediated phagocytosis by cyclic AMP and insulin in a macrophage-like cell line.

Authors:  R J Muschel; N Rosen; O M Rosen; B R Bloom
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

2.  Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon.

Authors:  E Knight
Journal:  Nature       Date:  1976-07-22       Impact factor: 49.962

3.  Interferon assay based on the inhibition of double-stranded reovirus RNA accumulation in mouse L cells.

Authors:  A Vassef; G Beaud; K Paucker; P Lengyel
Journal:  J Gen Virol       Date:  1973-04       Impact factor: 3.891

4.  Interferon and cyclic-3'5'-adenosine monophosphate: potentiation of antiviral activity.

Authors:  R M Friedman; I Pastan
Journal:  Biochem Biophys Res Commun       Date:  1969-08-22       Impact factor: 3.575

5.  Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.

Authors:  P Ralph; J Prichard; M Cohn
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

6.  Interferon preparations enhance phagocytosis in vivo.

Authors:  R M Donahoe; K Y Huang
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

7.  Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations.

Authors:  I Gresser; D Brouty-Boyé; M T Thomas; A Macieira-Coelho
Journal:  Proc Natl Acad Sci U S A       Date:  1970-08       Impact factor: 11.205

8.  Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.

Authors:  P Ralph; M A Moore; K Nilsson
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

9.  Isolation of variants in phagocytosis of a macrophage-like continuous cell line.

Authors:  R J Muschel; N Rosen; B R Bloom
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.

Authors:  M Nowakowski; J D Feldman; S Kano; B R Bloom
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 2.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Transcriptional induction of two genes in human cells by beta interferon.

Authors:  A C Larner; G Jonak; Y S Cheng; B Korant; E Knight; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Alpha interferon and gamma interferon stimulate transcription of a single gene through different signal transduction pathways.

Authors:  D J Lew; T Decker; J E Darnell
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.

Authors:  H R Hubbell; J E Boyer; P Roane; R M Burch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

6.  Cyclic AMP-dependent regulation of activities of synthetase and phosphodiesterase of 2',5'-oligoadenylate in NIH 3T3 cells.

Authors:  A V Itkes; K T Turpaev; O N Kartasheva; C A Kafiani; E S Severin
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

7.  A collection of mRNA species that are inducible in the RAW 264.7 mouse macrophage cell line by gamma interferon and other agents.

Authors:  J M Farber
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

8.  Interferons induce xanthine dehydrogenase gene expression in L929 cells.

Authors:  F Falciani; P Ghezzi; M Terao; G Cazzaniga; E Garattini
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

9.  Regulation of muscle acetylcholine receptor-channel function by interferon.

Authors:  F Eusebi; D Farini; F Grassi; A Santoni
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

Review 10.  Biologic agents as biochemical modulators: pharmacologic basis for the interaction of cytotoxic chemotherapeutic drugs and interferon.

Authors:  S Wadler; E L Schwartz
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.